Fractyl Health Inc Sustainability Reports
Fractyl Health, Inc. is a metabolic therapeutics company focused on pioneering disease-modifying treatments for metabolic diseases. The company develops procedural and gene therapies targeting the organ-level root causes of type 2 diabetes and obesity.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG002Y7NH81
1 reports from 2023 to 2023
Company Profile
Fractyl Health, Inc. is a metabolic therapeutics company focused on pioneering disease-modifying treatments for metabolic diseases. The company develops procedural and gene therapies targeting the organ-level root causes of type 2 diabetes and obesity.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years
